Novartis Oncology VP of Risk Salaries in Wilmington, DE | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology VP of Risk Salaries in Wilmington, DE

The average Novartis Oncology VP of Risk in Wilmington, DE earns an estimated $146,531 annually. Novartis Oncology's VP of Risk compensation is $3,576 more than the US average for a VP of Risk.

In Wilmington, DE, The Legal Department at Novartis Oncology earns $876 more on average than the Customer Support Department.

Last updated 3 years ago.

$46k
$85k
$116k
$143k
$194k
$250k
$146,531
Average Compensation
$146,531
avg. base

VP of Risk Salaries at Novartis Oncology

In Wilmington, DE, VPs of Risk earn $56,654 more than Contracts Specialists, and $48,049 less than Corporate Counsels.

General Counsel
$212k*
Corporate Counsel
$195k*
Contracts Specialist
$90k*
Paralegal
$70k*
* estimated salary

Compensation at Novartis Oncology by Department

In Wilmington, DE, The Legal Department averages $876 more than the Customer Support Department, and $33,182 less than the Product Department

Product
$174,968 Avg. total comp.
+$33k
Legal
$141,786 Avg. total comp.
Customer Support
$140,910 Avg. total comp.
-$876

VP of Risk Compensation by Gender (All Companies)

The average female VP of Risk at companies similar size to Novartis Oncology reported making $104,000, while the average male VP of Risk at similar sized companies reported making $157,000.

VP of Risk Compensation by Ethnicity (All Companies)

The average Hispanic or Latino VP of Risk at companies similar size to Novartis Oncology reported making $160,000, while the average Caucasian VP of Risk at similar sized companies reported making $132,000.

How VPs of Risk at Novartis Oncology Rate Their Compensation

The majority of VPs of Risk at Novartis Oncology believe they're not compensated fairly. 100% of VPs of Risk at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company